摘要
<br/>B-cell lymphoma-2 (Bcl-2) family proteins, comprising proapoptotic proteins (Bax and Bak), antiapoptotic proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and A1) and BCL-2 homology domain 3 (BH3)-only proteins (Bid, Noxa, and Puma), have long been identified as pivotal apoptosis regulators. As an antiapoptotic member, myeloid cell leukemin-1 (Mcl-1) can bind with proapoptotic proteins and inhibit apoptosis. Mcl-1 is frequently overexpressed and closely associated with oncogenesis and poor prognosis in several cancers, posing a tremendous obstacle for cancer therapy. Recently, an increasing number of Mcl-1-selective small-molecule inhibitors have entered preclinical studies and advanced into clinical trials. In this review, we briefly introduce the role of Mcl-1 in apoptosis and highlight the recent development of Mcl-1 small-molecule inhibitors.
- Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experimentsYue, Jianda; Li, Yaqi; Li, Fengjiao; Zhang, Peng; Li, Yimin; Xu, Jiawei; Zhang, Qianqian; Zhang, Cheng; He, Xiao; Wang, Ying*; Liu, Zhonghua*Computers in Biology and Medicine, 2023, 152: 106350.
- Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes.Respondek Michalina; Beberok Artur; Rzepka Zuzanna; Rok Jakub; Wrześniok DorotaPathology oncology research : POR , 2020, 26(3): 1465-1474.
- Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathwaysRuiz-Vela, Antonio*; Aggarwal, Mohit; de la Cueva, Palorna; Treda, Cezary; Herreros, Beatriz; Martfn-Perez, Daniel; Dominguez, Orlando; Piris, Miguel A.Blood, 2008, 111(3): 1665-1676.被引 17
